168152-68-9 Usage
Molecular weight
439.54 g/mol
The mass of one mole of the compound is 439.54 grams.
3. Tetrazole ring presence
The compound contains a tetrazole ring (two nitrogen and three carbon atoms in a five-membered ring), which contributes to its biological activity.
4. Bicyclic nonane structure
The compound has a bicyclic (two-ring) structure consisting of nine carbon atoms in total.
5. Class of tetrazine compounds
It belongs to the class of tetrazine compounds, which are known for their diverse biological activities.
6. Applications in pharmaceuticals and agrochemicals
Due to their various biological activities, tetrazine compounds like this one are commonly used in the development of pharmaceuticals and agrochemicals.
7. Reactivity and chemical behavior
The specific properties and uses of this compound depend on its reactivity and chemical behavior, which need further investigation through laboratory testing and analysis.
Check Digit Verification of cas no
The CAS Registry Mumber 168152-68-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,8,1,5 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 168152-68:
(8*1)+(7*6)+(6*8)+(5*1)+(4*5)+(3*2)+(2*6)+(1*8)=149
149 % 10 = 9
So 168152-68-9 is a valid CAS Registry Number.
InChI:InChI=1/C21H18N8/c1-13-19(14(2)29-21(24-13)22-12-23-29)11-15-7-9-16(10-8-15)17-5-3-4-6-18(17)20-25-27-28-26-20/h3-10,12H,11H2,1-2H3,(H,25,26,27,28)
168152-68-9Relevant articles and documents
TRIAZOLOPYRIMIDINE DERIVATIVES WHICH ARE ANGIOTENSIN II RECEPTOR ANTAGONISTS, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT
-
, (2008/06/13)
The present invention relates to the derivatives of the formula STR1 and their tautomeric forms, as well as their addition salts, and to their use in therapeutics, especially for the treatment and prevention of cardiovascular diseases and in particular for the treatment of hypertension, cardiac insufficiency and diseases of the arterial wall, especially atherosclerosis.
